| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023108A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000000636A3 In vivo determination of metabolic function for use in therapy management |
| 04/27/2000 | DE19849464A1 Stent with polymeric coating having pockets, preferably cyclodextrin stuctures, containing active agent for prophylaxis of restenosis |
| 04/27/2000 | CA2347085A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/26/2000 | EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 04/26/2000 | EP0995448A1 Diagnostic agents and remedies for malignant tumors |
| 04/26/2000 | EP0994730A2 LABELLED FACTOR XIIIa SUBSTRATES |
| 04/26/2000 | EP0670826B1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 04/26/2000 | EP0579802B1 Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents |
| 04/25/2000 | US6054117 Nuclear magnetic resonance contrast media for diagnostics and therapy; physiologically acceptable excretion |
| 04/25/2000 | US6054115 Purifying by exposing a mixture of uncoordinated hydroxyalkyl phosphine groups and coordinated hydroxyalkyl phosphine groups to an amine to separate the unbound coordinated groups from the bound uncoordinated groups |
| 04/25/2000 | US6054114 Diagnosing the degree of progression of alzheimer's disease in a mammal, monitoring the response to a therapy in a mammal having alzheimer's disease, identifying an agent useful for treating alzheimer's disease |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/20/2000 | WO2000022628A1 Highly radioactive miniaturized ceramic strontium 90 radiation source and method for the production thereof |
| 04/20/2000 | WO2000021982A1 A process for the preparation of a thrombus imaging agent |
| 04/20/2000 | WO2000021980A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents |
| 04/20/2000 | WO2000021573A1 Site-specific labeling of disulfide-containing targeting vectors |
| 04/20/2000 | WO2000021571A1 Ion exchange tumor targeting (iett) |
| 04/20/2000 | WO2000021560A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 04/20/2000 | WO1999064046A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
| 04/20/2000 | CA2341975A1 A process for the preparation of a thrombus imaging agent |
| 04/20/2000 | CA2341672A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents |
| 04/19/2000 | EP0993307A2 TECHNETIUM-99m LABELED CHELATOR INCORPORATED CYCLIC PEPTIDES |
| 04/19/2000 | EP0993306A1 Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis |
| 04/19/2000 | EP0993297A1 Dilating and support apparatus with disease inhibitors and methods for use |
| 04/18/2000 | US6051693 Human monoclonal antibody which preferentially binds to neoplastic cell over a normal cell of same tissue type; for diagnosis, anticarcinogenic agents and antitumor agents |
| 04/18/2000 | US6051387 Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies |
| 04/18/2000 | US6051230 For treatment and/or diagnosis (imaging) of vascularized solid tumors |
| 04/18/2000 | US6051229 Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051225 Family of high affinity, modified antibodies for cancer treatment |
| 04/18/2000 | US6051224 Compositions and methods for targeting cells and modulating pulmonary surfactant secretion |
| 04/18/2000 | US6051218 Administering cell expressing interleukin-3 |
| 04/18/2000 | US6051209 Determining effects of external stimuli on the brain using pet |
| 04/18/2000 | US6051207 Phosphatidylserine linked isoxazole sulfonamide derivatives; diagnosing and imaging cardiovascular disorders |
| 04/18/2000 | US6051206 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 04/18/2000 | CA2145983C Labelled monocyte chemoattractant protein material and medical uses thereof |
| 04/13/2000 | WO2000020640A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/13/2000 | WO2000020390A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 04/13/2000 | WO2000020044A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 04/13/2000 | WO2000020043A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO1999061072A3 Methods of inhibiting clot formation |
| 04/13/2000 | WO1999055387A8 Methods for detecting lesions in dense breast tissue using lhrh antagonists |
| 04/13/2000 | WO1999038500A3 The human calcium-sensing receptor in the detection and treatment of cancer |
| 04/13/2000 | DE19845798A1 Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of neoangiogenesis markers for diagnosis and therapy of tumors, compositions comprising them, and to processes for their preparation |
| 04/13/2000 | CA2346537A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 04/13/2000 | CA2346326A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2345285A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 04/13/2000 | CA2345000A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/12/2000 | EP0991427A2 Improvements in or relating to diagnostic/therapeutic agents |
| 04/12/2000 | CN1250361A Method to enhance tissue accumulation of radiolabeled compounds |
| 04/06/2000 | WO2000019450A1 Integrated radiation shied |
| 04/06/2000 | WO2000018440A1 Somatostatin receptor radioligand with increased uptake |
| 04/06/2000 | WO2000018439A2 Use of neoangiogenesis markers for diagnosing and treating tumours by therapy |
| 04/06/2000 | WO2000018403A1 Radiolabeled neurokinin-1 receptor antagonists |
| 04/06/2000 | WO2000018336A1 Targeted therapy to a biomedical device |
| 04/06/2000 | WO2000018331A2 Drug delivery systems |
| 04/06/2000 | WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 04/06/2000 | WO1999067284A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 04/06/2000 | WO1999062565A3 Patient-specific dosimetry |
| 04/06/2000 | WO1999058162A3 Pharmaceuticals for the imaging of angiogenic disorders |
| 04/06/2000 | CA2344561A1 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 04/06/2000 | CA2343106A1 Radiolabeled neurokinin-1 receptor antagonists |
| 04/06/2000 | CA2341489A1 Somatostatin receptor radioligand with increased uptake |
| 04/05/2000 | EP0990000A1 Connective tissue growth factor-3 |
| 04/05/2000 | EP0989865A1 Apparatus and method for preparing radioactive medicines for administration |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | EP0871608B1 Monofunctionalised EDTA-, DTPA- and TTHA-Derivatives and their use for the preparation of a diagnoctic or therapeutic medicine |
| 04/05/2000 | EP0733072B1 Antibody against carcinoembryonic antigen (cea) |
| 04/04/2000 | US6045821 Chelate compound immobilized on membrane whereby the chelating agent comprises a macrocyclic chelant moiety with a lipophilic membrane associating moiety attached to ring atom; organometallic compound medical diagnostic agents |
| 04/04/2000 | US6045774 Diagnosis of cancer and other disorders |
| 04/04/2000 | US6045773 Method of detecting cyclooxygenase-2 |
| 04/04/2000 | CA2105402C Radiolabelled compound formulations |
| 04/04/2000 | CA2031129C Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 03/30/2000 | WO2000017360A1 Cystine knot growth factor mutants |
| 03/30/2000 | WO2000017195A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/30/2000 | WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/30/2000 | WO2000002584A3 Cancer treatment methods using antibodies to aminophospholipids |
| 03/30/2000 | WO1999061066A9 Convection-enhanced delivery of aav vectors |
| 03/30/2000 | DE19842133A1 Rapid preparation of new or known fluorinated sugar derivatives, for use in vivo pharmacokinetic studies, by reacting pentose or hexose with fluoropyruvate using aldolase |
| 03/30/2000 | CA2344390A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/30/2000 | CA2344277A1 Cystine knot growth factor mutants |
| 03/30/2000 | CA2343918A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/29/2000 | EP0989137A2 Diagnostic agents for pancreatic exocrine function |
| 03/29/2000 | EP0989120A1 Reagents for assaying central local acetylcholinesterase activity |
| 03/29/2000 | EP0988634A1 PROCESS AND APPARATUS FOR PRODUCTION OF Bi-213 CATIONS |
| 03/29/2000 | EP0988035A1 Caspases and apoptosis |
| 03/29/2000 | CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process |
| 03/28/2000 | US6043283 Administering tyramine compound to patient to inhibit injury, destruction or death of neurons |
| 03/28/2000 | US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors |
| 03/23/2000 | WO2000015259A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells |
| 03/23/2000 | WO2000015231A1 Adenosine a3 receptor modulators |
| 03/23/2000 | WO1999055285A3 Dilating and support apparatus with disease inhibitors and methods for use |
| 03/23/2000 | WO1999040947A3 Angiogenesis targeting molecules |
| 03/23/2000 | CA2342601A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells |